This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Chr. Hansen Holding Inkomsten in het verleden

Verleden criteriumcontroles 3/6

Chr. Hansen Holding's earnings have been declining at an average annual rate of -1.1%, while the Chemicals industry saw earnings growing at 18.5% annually. Revenues have been growing at an average rate of 3.2% per year. Chr. Hansen Holding's return on equity is 12.8%, and it has net margins of 17.7%.

Belangrijke informatie

-1.1%

Groei van de winst

-1.1%

Groei van de winst per aandeel

Chemicals Groei van de industrie	13.1%
Inkomstengroei	3.2%
Rendement op eigen vermogen	12.8%
Nettomarge	17.7%
Volgende winstupdate	06 Jul 2023

Recente prestatie-updates uit het verleden

Recent updates

Opbrengsten en kosten

Hoe Chr. Hansen Holding geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

BMV:CHR N Opbrengsten, kosten en inkomsten (EUR Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven	R&D-uitgaven
28 Feb 23	1,294	229	268	98
30 Nov 22	1,259	228	263	98
31 Aug 22	1,218	225	256	97
31 May 22	1,183	230	248	94
28 Feb 22	1,146	221	238	96
30 Nov 21	1,102	209	232	93
31 Aug 21	1,077	199	228	90
31 May 21	1,038	199	213	80
28 Feb 21	1,014	213	202	77
30 Nov 20	994	222	193	74
31 Aug 20	970	232	188	73
31 May 20	798	218	160	69
29 Feb 20	844	221	174	70
30 Nov 19	888	224	184	71
31 Aug 19	937	229	193	70
31 May 19	1,152	246	228	76
28 Feb 19	1,132	240	223	75
30 Nov 18	1,112	233	218	74
31 Aug 18	1,097	228	210	73
31 May 18	1,084	226	208	74
28 Feb 18	1,080	224	206	73
30 Nov 17	1,075	224	206	72
31 Aug 17	1,063	224	205	70
31 May 17	1,035	212	199	67
28 Feb 17	1,007	205	193	65
30 Nov 16	976	192	183	63
31 Aug 16	949	184	179	60
31 May 16	927	179	175	57
29 Feb 16	905	174	170	54
30 Nov 15	885	172	168	53
31 Aug 15	859	163	163	51
31 May 15	830	150	158	49
28 Feb 15	800	141	152	46
30 Nov 14	773	133	150	45
31 Aug 14	756	132	147	43
31 May 14	745	145	148	42
28 Feb 14	738	142	150	40
30 Nov 13	731	135	151	37
31 Aug 13	738	138	152	35
31 May 13	730	126	166	20
28 Feb 13	719	125	158	24
30 Nov 12	710	135	149	27
31 Aug 12	699	129	141	31

Kwaliteitswinsten: CHR N has high quality earnings.

Groeiende winstmarge: CHR N's current net profit margins (17.7%) are lower than last year (19.3%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: CHR N's earnings have declined by 1.1% per year over the past 5 years.

Versnelling van de groei: CHR N's earnings growth over the past year (3.3%) exceeds its 5-year average (-1.1% per year).

Winst versus industrie: CHR N earnings growth over the past year (3.3%) exceeded the Chemicals industry -37.2%.

This company is no longer active

Chr. Hansen Holding Inkomsten in het verleden

Verleden criteriumcontroles 3/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

Chr. Hansen Holding A/S to Report Fiscal Year 2024 Results on Feb 06, 2025

First quarter 2023 earnings released: EPS: €0.38 (vs €0.35 in 1Q 2022)

Chr. Hansen Holding A/S to Report Q1, 2023 Results on Dec 12, 2022

Full year 2022 earnings released: EPS: €1.71 (vs €1.51 in FY 2021)

Chr. Hansen Holding A/S to Report Q2, 2023 Results on Apr 13, 2023

Third quarter 2022 earnings released: EPS: €0.45 (vs €0.38 in 3Q 2021)

Recent updates

Chr. Hansen Holding A/S(CPSE:CHR) dropped from FTSE All-World Index (USD)

Chr. Hansen Holding A/S(CPSE:CHR) dropped from OMX Copenhagen 20 Index

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Chr. Hansen Holding A/S to Report Fiscal Year 2024 Results on Feb 06, 2025

Chr. Hansen Holding A/S Revises Revenue Guidance for January 1, 2023 – December 31, 2023

Novozymes A/S and Chr. Hansen Announce Executive Leadership Team and Organizational Structure

Chr. Hansen Holding A/S Provides Earnings Guidance for the Period September 1, 2022 – August 31, 2023

Executive VP recently bought Mex$1.5m worth of stock

First quarter 2023 earnings released: EPS: €0.38 (vs €0.35 in 1Q 2022)

Chr. Hansen Holding A/S Provides Revenue Guidance for 2022/23

Novozymes A/S (CPSE:NZYM B) agreed to acquire Chr. Hansen Holding A/S (CPSE:CHR).

Novozymes A/S (CPSE:NZYM B) agreed to acquire Chr. Hansen Holding A/S (CPSE:CHR).

Key Executive recently bought Mex$135k worth of stock

Chr. Hansen Holding A/S Approves Ordinary Dividend

Upcoming dividend of kr.7.04 per share

High number of new directors

Chr. Hansen Holding A/S to Report Q1, 2023 Results on Dec 12, 2022

Full year 2022 earnings released: EPS: €1.71 (vs €1.51 in FY 2021)

Chr. Hansen Holding A/S Proposes Ordinary Dividend for 2021/22

High number of new directors

Chr. Hansen Holding A/S to Report Q2, 2023 Results on Apr 13, 2023

Third quarter 2022 earnings released: EPS: €0.45 (vs €0.38 in 3Q 2021)

Chr. Hansen Holding A/S Provides Earnings Guidance for the Full Year of Fiscal 2022

High number of new directors

Opbrengsten en kosten

Inkomsten en omzetgeschiedenis

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Rendement op eigen vermogen

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden